First Horizon Corporation’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.88K Buy
53
+18
+51% +$1.63K ﹤0.01% 1210
2026
Q1
$3.04K Buy
35
+5
+17% +$486 ﹤0.01% 1229
2025
Q4
$3.21K Buy
+30
New +$3.18K ﹤0.01% 1270

Other funds holding RYTM

First Horizon Corporation's RYTM Position: Q2 2026 in Review

First Horizon Corporation increased its Rhythm Pharmaceuticals (RYTM) stake by 51% in Q2 2026, buying an estimated $1.63K and bringing the position to 53 shares worth $5.88K. The position accounts for ﹤0.01% of the portfolio, ranked #1210.

First Horizon Corporation first reported a position in RYTM in Q4 2025 and has held it in 3 quarters since. 52 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • First Horizon Corporation held 53 shares of Rhythm Pharmaceuticals worth $5.88K as of Q2 2026.
  • First Horizon Corporation bought 18 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $1.63K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1210 holding.
  • First Horizon Corporation first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 52 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.